baber/WOPTO huggingface dataset:
Patent EP-4210999-A1 (EP)
Inventor: LIU ZU JIAN
IPC: B60N2/28
Filed: 2021-10-12
Abstract: A child safety seat (100) is provided and includes a base (10), a seat body (20) installed on the base (10), a locking device (40), a locked portion (11) and an operating component (30) movably linked to the locking device (40). The seat body (20) is switchable between a forward-facing orientation and a rearward-facing orientation. The locking device (40) and the locked portion (11) are respectively disposed on one and another one of the seat body (20) and the base (10). The locking device (40) engages with the locked portion (11) when the seat body (20) is located in the forward-facing orientation or the rearward-facing orientation. The operating component (30) drives the locking device (40) to disengage from the locked portion (11) for allowing the seat body (20) to switch between the forward-facing orientation and the rearward-facing orientation.
Patent EP-4244201-A1 (EP)
Inventor: MARRIOTT RAY
IPC: C07C37/00
Filed: 2021-10-21
Abstract: The present invention discloses a method for extracting cannabidiol from dried, milled and decarboxylated hemp by submitting to a subcritical liquid carbon dioxide extraction followed by a mild liquid carbon dioxide separation.
Patent EP-4211034-A1 (EP)
Inventor: BLACK NICHOLAS
IPC: B63H8/20
Filed: 2021-09-07
Abstract: La présente invention concerne un appareil de verrouillage prévu pour fixer de manière libérable une charge, telle qu'une voile, à une structure de support, telle qu'un mât, tandis que la charge applique une force dans une direction de charge. L'appareil de verrouillage comprend un élément de verrouillage fixé ou pouvant être fixé à la charge et un ensemble de verrouillage destiné à être fixé à la structure de support. L'ensemble de verrouillage comprend au moins un élément de verrouillage configuré pour se déplacer entre une position verrouillée dans laquelle l'élément de verrouillage bloque le mouvement de l'élément de verrouillage dans la direction de charge, et une position déverrouillée, un actionneur, et un couplage libérable pour coupler l'actionneur à l'élément de verrouillage. Le couplage est conçu pour coupler l'actionneur à l'élément de verrouillage lors du déplacement de l'élément de verrouillage vers l'actionneur dans une direction d'insertion, opposée à la direction de charge. Le mouvement ultérieur de l'élément de verrouillage dans la direction de charge transporte d'abord l'actionneur dans la direction de charge pour déplacer l'élément de verrouillage vers la position verrouillée, amène ensuite le couplage à découpler l'actionneur de l'élément de verrouillage et à amener l'élément de verrouillage en prise avec l'élément de verrouillage, ce qui permet de maintenir l'élément de verrouillage dans la position verrouillée pour bloquer un mouvement supplémentaire de l'élément de verrouillage dans la direction de charge. L'appareil est approprié pour une utilisation en tant que verrou de drisse dans un voilier.
Patent EP-4229209-A1 (EP)
Title: A process to treat a carbon dioxide comprising gas
Inventor: LIU DANDAN
IPC: C12P5/02
Filed: 2021-10-13
Abstract: The invention is directed to a process to convert carbon dioxide to methane by contacting an aqueous solution comprising dissolved carbon dioxide with an electron charged packed bed comprising of a carrier, suitably activated carbon granules, and a biofilm of microorganisms under anaerobic conditions, wherein more than 90 mol% of the dissolved carbon dioxide in the aqueous solution is present as a bicarbonate ion and/or as a carbonate ion.
Patent EP-4232095-A1 (EP)
Title: Means and methods for producing antibody-linker conjugates
Inventor: SPYCHER PHILIPP
IPC: A61K47/68
Filed: 2021-10-25
Abstract: The present invention relates to a method for generating an antibody-payload conjugate by means of a microbial transglutaminase (MTG). The method comprises a step of conjugating a linker comprising the structure (shown in N -> C direction) (Sp 1 )-RK-(Sp 2 )-B-(Sp 3 ) or (Sp 1 )- B-(Sp 2 )-RK-(Sp 3 ) to a Gin residue comprised in an antibody, wherein (Sp 1 ) is a chemical spacer or is absent; (Sp 2 ) is a chemical spacer or is absent; (Sp 3 ) is a chemical spacer or is absent; R is arginine or an arginine derivative or an arginine mimetic; K is lysine or a lysine derivative or a lysine mimetic; B is a linking moiety or a payload; and wherein the linker is conjugated to the Gln residue comprised in the antibody via a primary amine comprised in the side chain of the lysine residue, the lysine derivative or the lysine mimetic. Further, the invention relates to antibody-linker conjugates, antibody-drug conjugates and linker constructs comprising an RK motif.
Patent EP-4205204-A1 (EP)
Title: Bipolarplatte mit medienregulierung und brennstoffzellenstapel
Inventor: GRETZER MARKUS
IPC: H01M8/043
Filed: 2021-10-25
Abstract: Die Erfindung betrifft eine Bipolarplatte (1) für eine Brennstoffzelle (2) mit einem aktiven Bereich (3) und einem den aktiven Bereich (3) umgebenden Randbereich (4), dem eine einen ersten Durchtritt (5) aufweisende erste Medienführung (10) und eine einen zweiten Durchtritt (6) aufweisende zweite Medienführung (7) zugeordnet ist, sowie mit einem durch den aktiven Bereich (3) verlaufenden, den ersten Durchtritt (5) mit dem zweiten Durchtritt (6) strömungsmechanisch verbindenden Medienkanal (8), wobei dem ersten Durchtritt (5) und/oder dem zweiten Durchtritt (6) eine Blende (9) zugeordnet ist, die mittels eines Aktuators zur Einstellung oder zur Regelung des Strömungsquerschnitts des ersten Durchtritts (5) und/oder des zweiten Durchtritts (6) verstellbar ist. Die Erfindung betrifft darüber hinaus einen Brennstoffzellenstapel (14).
Patent EP-4237866-A1 (EP)
Title: Method and apparatus for magnetic resonance imaging
Inventor: WEINGÄRTNER SEBASTIAN DANIEL
IPC: G01R33/385
Filed: 2021-10-28
Abstract: Method for magnetic resonance imaging, MRI, comprising obtaining an image acquisition sequence comprising RF pulses and magnetic field gradients configured to encode spatial information in a part of an object; obtaining an acoustic noise cancelling signal corresponding to the obtained image acquisition sequence at a first position; generating the image acquisition sequence; wherein the magnetic fields gradients are generated by gradient coils configured for three orthogonal directions respectively; and converting, by an acoustic transducer, simultaneously with the image acquisition sequence, the predetermined noise cancelling signal to an acoustic noise cancelling signal at the first position. The noise cancelling signal is obtained based on an acoustic transfer function and the magnetic field gradients of the image acquisition sequence, wherein the acoustic transfer function is obtained by training a neural network on a plurality of generic image acquisition sequences followed by transfer learning with calibration image acquisition sequences obtained during a calibration state before the generating of the image acquisition sequence.
Patent EP-4152819-A1 (EP)
Inventor: LIU JIAMIN
IPC: H04W36/18
Filed: 2021-05-10
Abstract: Disclosed are a handover method and apparatus, a user equipment, and a network device. The handover method comprises: receiving a first message sent by a source cell, wherein the first message is used for instructing to carry out the handover of a relay terminal to a target cell, the first message carries target configuration information in the target cell, the target configuration information comprises: first configuration information of the relay terminal, and second configuration information of data of a remote terminal on a Uu interface, and the remote terminal is a remote terminal under the relay terminal; and accessing the target cell according to the target configuration information.
Patent EP-4192531-A1 (EP)
Inventor: BEDI VIJAY
IPC: A61L2/18
Filed: 2021-05-07
Abstract: A composition that includes an effective amount of a quaternary ammonium silane compound; an effective amount of a benzalkonium chloride compound; between 50 volume percent and 90 volume percent of a short chain alcohol have between one and six carbon atoms; and between 10 percent and 50 percent water. The composition is effective at reducing or eliminating one or more pathogens from a contact surface and preventing recolonization for an interval of at least one hour in certain applications. In certain applications and embodiments, the pathogen eliminated can be one of at least viruses, bacteria, fungi and spores including but not limited to SARS-CoV-2.
Patent EP-4171547-A1 (EP)
Inventor: OALMANN CHRISTOPHER J
IPC: A61P37/02
Filed: 2021-05-26
Abstract: La présente invention concerne des composés qui modulent l'activité de protéines du récepteur de type Toll (TLR), y compris les agonistes ou les activateurs, les agonistes partiels et les antagonistes. Les composés qui modulent l'activité de TLR2, ainsi que des procédés d'utilisation de tels composés pour traiter le cancer et d'autres troubles associés à une voie de TLR2 sont d'un intérêt particulier.
Patent EP-4159718-A1 (EP)
Inventor: SONG MINSOO
IPC: A61K31/445
Filed: 2021-04-05
Abstract: Disclosed are a sulfonamide derivative and a pharmaceutical composition comprising same as an active ingredient for use in preventing or treating mental illness. The derivative is superbly effective in a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, and thus can be effectively used in treating mental illness.
Patent EP-4229068-A1 (EP)
Inventor: KIER BRANDON
IPC: C07K1/04
Filed: 2021-10-13
Abstract: The present disclosure relates to the field of affinity chromatography, and more specifically to the provision of nucleic acid and polypeptide libraries encoding three-helix bundle protein domains suitable for selecting affinity ligands that specifically binds to a target molecule of interest. The disclosure also relates to methods of using those libraries to identify and isolate such affinity ligands to a target molecule.
Patent EP-4243711-A1 (EP)
Title: Surgical access device having plural zero closure valves
Inventor: BARIL JACOB C
IPC: A61B17/34
Filed: 2021-11-04
Abstract: A surgical access device includes a seal assembly, an upper housing portion, a lower housing portion, and a tubular member. The seal assembly has an instrument seal and is coupled to the upper housing portion. A first valve is partially disposed in an upper chamber of the upper housing portion and a second valve is partially disposed in a lower chamber of the lower housing portion. A valve assembly extends from the upper housing portion and is in fluid communication with the upper chamber. A source of insufflation fluid is attachable to the valve assembly.
Patent EP-4226947-A1 (EP)
Inventor: VALDÉS BALBÍN YURY
IPC: A61K47/64
Filed: 2021-10-05
Abstract: This invention pertains to biotechnology, more specifically to the field of human health. This document describes in particular conjugates of the SARS-CoV-2 receptor binding domain covalently conjugated to a carrier protein, the method used to obtain them, and the vaccine compositions that contain them. The vaccine compositions described in this invention are useful for the prevention of the SARS-CoV-2 infection as they induce a strong response of neutralizing antibodies.
Patent EP-4247336-A1 (EP)
Inventor: OSBORNE DAVID W
IPC: A61K9/00
Filed: 2021-11-16
Abstract: Pharmaceutical compositions for the topical administration of a drug to the pilosebaceous unit and methods for administering the same. As disclosed herein, the inventors of the present invention have made the surprising discovery that pharmaceutical compositions comprising small particles of an active pharmaceutical ingredient can be administered to the pilosebaceous unit The pharmaceutical composition can comprise SHR0302 or spironolactone as an active pharmaceutical ingredient.
Patent EP-4264476-A1 (EP)
Inventor: CORDES CLAUDIA GISELA
IPC: G06F30/20
Filed: 2021-12-14
Abstract: A computer implemented method for predicting at least one mechanical property of at least one composite element (110) comprising at least two layers (112) is disclosed. Each layer (112) comprises a network (114) having repeating units (120) which comprise nodes (116) and edges (118). Each layer (112) has a volume, a longitudinal extension and a maximum height h vertical to the longitudinal extension and comprises a material with cellular structure. The layers (112) are stacked. The method comprises the following steps: a) providing at least one input parameter set, wherein the input parameter set comprises a plurality of parameters defining properties of each of the single layers (112); b) determining at least one geometric model of the composite element based on the input parameter set using at least one design tool (126); c) determining at least one mechanical property of the geometric model of the composite element by using at least one numerical simulation (130), wherein the mechanical property comprises one or more of tension property, pressure property, shear property, temperature property and a combination thereof.
Patent EP-4182670-A1 (EP)
Inventor: RAWLE CHRISTOPHER BRUCE
IPC: G01N1/44
Filed: 2021-07-16
Abstract: An apparatus is provided for processing and analysing a biological sample; the apparatus comprising: a. an apparatus housing; b. a sample extraction system to receive and hold the biological sample, and to extract the biological sample into a microfluidic chip; c. a thermal system to control the temperatures of the biological sample in the sample extraction system, and the extracted biological sample in the microfluidic chip; d. an optical system to illuminate the processed sample in the chip and to generate fluorescence from the sample in the chip, and an optical detector configured to detect the fluorescence; and e. at least one controller to control the sample extraction system, the thermal system and the optical system, and to determine one or more properties of the sample. The apparatus is configured to be handheld, and to extract and analyse the sample in situ, without requiring laboratory equipment.
Patent EP-4185584-A1 (EP)
Title: Srebp inhibitors comprising a thiophene central ring
Inventor: GREEN MICHAEL JOHN
IPC: C07D409/14
Filed: 2021-07-23
Abstract: Provided herein are compounds comprising a three-ring core and pharmaceutically acceptable salts, solvates, tautomers, isotopes, or isomers thereof. Also provided herein are methods of inhibiting a component of the sterol regulatory element binding protein (SREBP) pathway, such as an SREBP or SREBP cleavage activating protein (SCAP), using these compounds, or pharmaceutically acceptable salts, solvates, tautomers, isotopes, or isomers thereof. Further provided are methods of treating a disorder in a subject in need thereof, such as liver disease, non-alcoholic steatohepatitis, insulin resistance, or cancer.
Patent EP-4201972-A1 (EP)
Inventor: TAGUCHI YUUKI
IPC: C08F265/06
Filed: 2021-07-29
Abstract: A thermoplastic resin composition including a graft copolymer (B) produced by graft polymerization of a vinyl monomer mixture (m1) including an alkyl (meth)acrylate ester, a vinyl cyanide compound, and an aromatic vinyl compound onto a copolymer (A) produced by copolymerizing an alkyl (meth)acrylate ester (a) and a (meth)acrylate ester (b) including an aromatic hydrocarbon group at a specific ratio and a copolymer (C) that is a product of a polymerization reaction of a vinyl monomer mixture (m2) including an alkyl (meth)acrylate ester. The graft copolymer (B) includes at least a graft copolymer (B) having a specific volume-average particle size. The copolymer (A) has a specific volume-average particle size and a specific particle size distribution.
Patent EP-4197662-A1 (EP)
Inventor: TAKENOUCHI HIROSHI
IPC: C22B23/00
Filed: 2021-08-05
Abstract: Provided is a method for treating a sulfide, the method being suitable for obtaining nickel and/or cobalt from a sulfide containing copper and nickel and/or cobalt. The method relates to a method for treating a sulfide containing copper and nickel and/or cobalt, the method including pulverizing the sulfide by subjecting the sulfide to a pulverizing treatment so as to obtain a pulverized sulfide having a particle size of 800 um or less; and leaching the pulverized sulfide by subjecting the pulverized sulfide to a leaching treatment with an acid under a condition in which a sulfurizing agent is present to obtain a leachate. For example, the sulfide to be treated is generated by reducing, heating, and melting a waste lithium-ion battery to obtain a molten body and adding a sulfurizing agent to the molten body to sulfurize the molten body.
Patent EP-4207760-A1 (EP)
Title: Scene switching-based image group partitioning method and apparatus, and video encoding method and apparatus
Inventor: CHEN DAPENG
IPC: H04N19/142
Filed: 2021-07-23
Abstract: Disclosed are a scene switching-based image group partitioning method and apparatus, and a video encoding method and apparatus. The scene switching-based image group partitioning method comprises: determining whether a scene switching frame is present in the received current image group; in response to the fact that at least one scene switching frame is present in the current image group, determining whether the last video frame of the current image group is a scene switching frame, if yes, determining the first scene switching frame of the current image group as a target scene switching frame, and if not, traversing the scene switching frames in the current image group from back to front to obtain the target scene switching frame; using a previous video frame of the target scene switching frame as the last video frame of the current image group, using a specified number of video frames that follow the target scene switching frame and comprise the target scene switching frame as the next image group, using the next image group as the current image group, and returning to determine whether a scene switching frame is present in the received current image group.
Patent EP-4224662-A1 (EP)
Inventor: TAKAO HIROSHI
IPC: H02J7/00
Filed: 2021-08-30
Abstract: Management device (30) manages storage modules (M1) each parallel-connected to power supply (60, 2) through switch (RY1). Determination unit (313) of management device (30), in a state where switches (RY1) connected to some of power storage modules (M1) in the power storage modules (M1) are on; and switches (RY1) connected to the remaining power storage modules (M1) are off, when at least one of the off-state switches (RY1) are turned on, determination unit (313) does not permit the switch (RY1) to be turned on when a maximum value of current or power allowed to charge all of the power storage modules (M1) is lower than a threshold based on the maximum before the switches (RY1) are is turned on.
Patent EP-4222787-A1 (EP)
Inventor: BARR MILES C
IPC: H01L31/048
Filed: 2021-09-30
Abstract: This application relates generally to the field of photovoltaic materials and devices, and, more particularly, to insulated glass units combining a visibly transparent (or semitransparent) photovoltaic structure and a low emissivity structure to provide a color neutral insulated glass unit while also improving the solar heat gain coefficient as compared to the use of the visibly transparent (or semitransparent) photovoltaic structure alone. In some embodiments, the photovoltaic and low emissivity structures are formed on separate lites (i.e., pieces of glass) and combined during fabrication of the insulated glass unit.
Patent EP-4226410-A1 (EP)
Inventor: ZAATO FRANCIS
IPC: H01L21/02
Filed: 2021-10-05
Abstract: A laminate structure and a method used in the manufacturing of flexible microelectronics devices are provided. The laminate structure comprises a rigid substrate, a flexible microelectronics structure comprising and a debonding structure provided between the rigid substrate and the flexible microelectronics structure. The debonding structure comprises at least one debonding layer made of a non-metallic inorganic material. The laminate structure comprises first and second peeling surfaces, where at least one of the peeling surfaces corresponding to a surface of the debonding structure or to a surface within the debonding structure. The first and second peeling surfaces are peelable by a debonding force resulting from a mechanical delamination and/or from a pressurized fluid delamination, allowing separating the flexible microelectronic device from the rigid substrate.
Patent EP-4230373-A1 (EP)
Inventor: ASADA TEPPEI
IPC: B27N1/02
Filed: 2021-10-12
Abstract: A method for manufacturing a fiber board is provided, the method enabling boards with a stable quality to be easily manufactured also when Palmae plants having a low bulk density are employed. An adhesive is added to woody fibers obtained by steaming and defibrating a woody material. Then, the woody fibers are formed and are subjected to thermocompression molding. The woody material includes a compressed material obtained by compressing and integrating together a plurality of dried ground products of a Palmae plant.
Patent EP-4236390-A1 (EP)
Title: Method and system for realizing service-based mobile originated short message service
Inventor: LIU LIU
IPC: H04W4/14
Filed: 2021-10-18
Abstract: Provided are a method and system for realizing a service-based mobile originated short message service. The method for realizing a service-based mobile originated short message service (MO SMS) comprises: after receiving a short message sent by a user terminal, an SMSF entity querying, from an NRF entity, information of a network function that can provide an MO SMS forwarding service; when it is determined, according to a query result, that a corresponding SMS-IWMSC can provide the MO SMS forwarding service, the SMSF entity sending the short message to the SMS-IWMSC; and the SMS-IWMSC sending the short message to an SC, so that the SC sends the short message to a corresponding short message receiver.
Patent EP-4245307-A1 (EP)
Inventor: CHANG JONG WOOK
IPC: A61K35/28
Filed: 2021-11-09
Abstract: Provided is a composition for preventing or treating a muscle disease, the composition including: a stem cell expressing growth-regulated oncogene-alpha (GRO-α); and/or GRO-α, wherein GRO-α inhibits death of muscle cells or skeletal muscle myoblasts. Thus, the composition can be used as an agent for prevention or treatment of various muscle diseases.
Patent EP-4249475-A1 (EP)
Title: Compound having inhibitory activity against o-glcnacase and use thereof
Inventor: KIM HEE
IPC: C07D277/46
Filed: 2021-11-19
Abstract: The present invention relates to a novel compound having inhibitory activity against O-GlcNAcase and a use thereof.
Patent EP-4183211-A1 (EP)
Inventor: YAO CHUNHAI
IPC: H04L5/00
Filed: 2021-09-23
Abstract: This disclosure relates to techniques for performing wireless communications including determination of actual time windows for maintaining power consistency and/or phase continuity associated with transmission between a user equipment (UE) and a base station. Techniques for determining the length, begging, and end of such windows are disclosed. A UE and/or base station may use various rules to determine the window (s).
Patent EP-4255934-A1 (EP)
Title: Constructions de fc iga hétérodimères et leurs procédés d'utilisation
Inventor: ESCOBAR-CABRERA ERIC
IPC: C07K16/46
Filed: 2021-12-03
Abstract: La présente invention concerne des constructions de Fc IgA (HetFc d'IgA) hétérodimères comprenant une ou plusieurs mutations d'acides aminés dans le domaine CH3 qui permettent la formation d'un Fc hétérodimère ayant une pureté et une thermostabilité élevées. Les constructions de HetFc IgA peuvent comprendre un ou plusieurs domaines de liaison cibles. Des multimères de HetFc IgA d'ordre supérieur comprenant de multiples constructions de HetFc d'IgA peuvent être préparés, deux des constructions de HetFc IgA sont liées par une chaîne J.